000 | 01855 a2200457 4500 | ||
---|---|---|---|
005 | 20250514162630.0 | ||
264 | 0 | _c20040205 | |
008 | 200402s 0 0 eng d | ||
022 | _a0955-3002 | ||
024 | 7 |
_a10.1080/09553000310001610277 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aDittmann, K | |
245 | 0 | 0 |
_aBowman-Birk protease inhibitor activates DNA-dependent protein kinase and reduces formation of radiation-induced dicentric chromosomes. _h[electronic resource] |
260 |
_bInternational journal of radiation biology _cOct 2003 |
||
300 |
_a801-8 p. _bdigital |
||
500 | _aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_aCarcinoma, Bronchogenic _xgenetics |
650 | 0 | 4 | _aCell Line |
650 | 0 | 4 |
_aCell Survival _xdrug effects |
650 | 0 | 4 |
_aChromosome Aberrations _xdrug effects |
650 | 0 | 4 | _aDNA-Activated Protein Kinase |
650 | 0 | 4 | _aDNA-Binding Proteins |
650 | 0 | 4 | _aDose-Response Relationship, Radiation |
650 | 0 | 4 |
_aEnzyme Activation _xdrug effects |
650 | 0 | 4 |
_aEnzyme Activators _xpharmacology |
650 | 0 | 4 |
_aFibroblasts _xdrug effects |
650 | 0 | 4 |
_aLung Neoplasms _xmetabolism |
650 | 0 | 4 |
_aProtein Serine-Threonine Kinases _xdrug effects |
650 | 0 | 4 | _aRadiation Dosage |
650 | 0 | 4 |
_aRadiation-Protective Agents _xpharmacology |
650 | 0 | 4 |
_aSevere Combined Immunodeficiency _xembryology |
650 | 0 | 4 |
_aTrypsin Inhibitor, Bowman-Birk Soybean _xpharmacology |
650 | 0 | 4 | _aTumor Cells, Cultured |
650 | 0 | 4 |
_aTumor Suppressor Protein p53 _xdrug effects |
700 | 1 | _aVirsik-Köpp, P | |
700 | 1 | _aMayer, C | |
700 | 1 | _aRave-Fränk, M | |
700 | 1 | _aRodemann, H P | |
773 | 0 |
_tInternational journal of radiation biology _gvol. 79 _gno. 10 _gp. 801-8 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1080/09553000310001610277 _zAvailable from publisher's website |
999 |
_c14366913 _d14366913 |